Non-nucleoside adenosine deaminase inhibitors: 2000 – 2004

By Terasaka Tadashi  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 817-828

Informa Healthcare

Access to resources Recommend Favorite

Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine

By White T.D.  

European Journal of Pharmacology, Vol. 303, Iss. 1, 1996-05 ,pp. : 27-38

Elsevier

Access to resources Recommend Favorite

Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-d-aspartate-evoked adenosine formation in cortex

By Hebb M.O.   White T.D.  

European Journal of Pharmacology, Vol. 344, Iss. 2, 1998-03 ,pp. : 121-125

Elsevier

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of a Novel Series of Indole-3- Carboxamide Derivatives for Cancer Treatment as EGFR Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 1, 2018-01 ,pp. : 70-83

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinamide derivatives as selective inhibitors of PDE4

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 481-485

Informa Healthcare

Access to resources Recommend Favorite